Cargando…
Accelerating clinical trial implementation in the context of the COVID-19 pandemic: author's response
Autores principales: | Trøseid, Marius, Diallo, Alpha, Hites, Maya, Røttingen, John-Arne, Yazdanpanah, Yazdan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752190/ https://www.ncbi.nlm.nih.gov/pubmed/35031489 http://dx.doi.org/10.1016/j.cmi.2021.12.014 |
Ejemplares similares
-
Accelerating clinical trial implementation in the context of the COVID-19 pandemic: challenges, lessons learned and recommendations from DisCoVeRy and the EU-SolidAct EU response group
por: Diallo, Alpha, et al.
Publicado: (2022) -
Assessing the evidence on remdesivir
por: Trøseid, Marius, et al.
Publicado: (2021) -
Re: Accelerating clinical trial implementation in the context of the COVID-19 pandemic by Diallo et al
por: Rys, Andrzej, et al.
Publicado: (2022) -
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial
por: Ader, Florence, et al.
Publicado: (2022) -
Jaundice in a patient treated with Anakinra in a context of Covid-19
por: Tarhini, H., et al.
Publicado: (2021)